Navigating Cancer’s Financial Strain: A Guide for Benefit and Health Plan Leaders
Join this webcast to discuss the economic challenges faced by cancer patients and explore how entities that manage their care and wellbeing can mitigate these burdens and downstream effects.
Cost: Complimentary
Date: Wednesday, November 13, 2024
Time: 2pm ET | 11am PT
Produced and Sponsored by:
Cancer is not just a disease; it can be a personal financial catastrophe. You know about the direct costs—imaging, biopsies, surgeries, therapies—but the hidden costs, like side-effect management, transportation, work, family and life disruptions, caregiving, and lifestyle supports, often push patients to the brink. In fact, according to a study published in the National Library of Medicine, over 42% of cancer patients deplete their assets and 30% incur debt by the second year of diagnosis.
Join this webcast to discuss the economic challenges faced by cancer patients and explore how entities that manage their care and wellbeing can mitigate these burdens and downstream effects. You’ll learn:
- The economic challenges faced by cancer patients
- How to enhance benefits, develop supportive policies, and advise clients on best practices
- The insights and tools needed to create a comprehensive and financially effective cancer program for those affected by the disease
Register Now
Can’t attend? Register here for an on-demand recording after the webcast.
Featured Speakers:
| Dr. Rebecca Miksad | Chief Medical Officer | Color Health Dr. Rebecca Miksad is a mission-driven Physician-Scientist with extensive expertise in cancer and patient-centric health technology and AI solutions. As Chief Medical Officer at Color Health, she oversees Color’s medical and clinical functions, driving the expansion of cancer screening, diagnostics, care navigation, and survivorship tools for program participants. Dr. Miksad previously founded and led the Strategic Affairs team and Research Unit at Flatiron Health, developing pioneering healthtech products and establishing industry standards for real-world data. | |
| Lily Servais | Medical Science Liaison | Color Health Lily Servais (she/her) is a Medical Science Liaison at Color Health. She is a seasoned genetic counselor with over 15 years of experience, specializing in cancer risk assessment and care. As a certified ACS LIONTM, she also serves as a care advocate and case manager, dedicated to providing comprehensive support to her patients. | |
| Robin Yabroff, PhD | Scientific Vice President, Health Services Research | American Cancer Society Robin Yabroff, PhD, is an epidemiologist and Scientific Vice President, Health Services Research, at the American Cancer Society. She conducts research on the economic burden of cancer; patterns of cancer care, including high-cost prescription drugs; health insurance benefit design; and patient, provider, and health system factors associated with the quality and value of cancer care. Dr. Yabroff has more than 25 years of health services research experience and currently has adjunct positions within the Department of Medicine, Johns Hopkins University, and the Rollins School of Public Health, Emory University. |